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The concept of the post-antibiotic era is 
becoming a reality, with patients presenting 
with infections from bacterial pathogens 
that resist multiple last line antibiotics 
while at the same time, very few novel 
antimicrobial drugs are coming onto the 
market.[1–5] As multi-antibiotic resistance 
becomes widespread,[6] the prevention of 
bacterial infections has become an urgent 
healthcare priority in order to reduce mor-
bidity and mortality.[7–9] Medical-device-
related infections are a consequence of 
planktonic bacteria attaching to the surface 
of implanted devices and developing into 
surface-associated “slime” layers called bio-
films, which have been reported to be 1000 
times more resistant to antibiotic and host 
immune system clearance.[10–13]
High throughput materials discovery 
screens have been utilized to discover 
poly mers that reduce bacterial surface col-
onization in order to circumvent our poor 
understanding of material surface-bacteria 
interactions that leaves us ill-equipped to 
design new materials from first princi-
ples.[14] Novel coatings were identified by screening a commer-
cially available (meth)acrylate monomer library for polymers 
that successfully reduced biofilm formation by P. aeruginosa, 
S. aureus, and E. coli in laboratory cultures in vitro and in vivo 
in a foreign body mouse infection model.[15,16] Such screening 
experiments facilitate the rapid assessment of readily available 
monomers to identify hit materials for a particular application, 
such as reducing bacterial fouling of surfaces in industry and 
healthcare, the expansion of pluripotent stem cells, increasing 
the maturation of cardiomyocyte derived from stem cells, and 
providing bioinstructive implant materials.[16–19]
To maximize the productivity of materials discovery screening 
campaigns, the monomer building blocks should ideally be 
cheap, easy to process, and readily accessible, i.e., not requiring 
time consuming bespoke synthesis. Acrylate/acrylamide mono-
mers that are commercially available with wide chemical diver-
sity (hundreds of different compounds) are suitable for this as 
they are readily printable and amenable to in situ polymeriza-
tion.[20,21] To synthesize variants of these materials in-house, 
we have used a single step, transesterification synthesis (see 
scheme Figure S1a in the Supporting Information) that utilizes 
Synthetic materials are an everyday component of modern healthcare yet 
often fail routinely as a consequence of medical-device-centered infections. 
The incidence rate for catheter-associated urinary tract infections is 
between 3% and 7% for each day of use, which means that infection 
is inevitable when resident for sufficient time. The O’Neill Review on 
antimicrobial resistance estimates that, left unchecked, ten million people 
will die annually from drug-resistant infections by 2050. Development 
of biomaterials resistant to bacterial colonization can play an important 
role in reducing device-associated infections. However, rational design 
of new biomaterials is hindered by the lack of quantitative structure–
activity relationships (QSARs). Here, the development of a predictive 
QSAR is reported for bacterial biofilm formation on a range of polymers, 
using calculated molecular descriptors of monomer units to discover and 
exemplify novel, biofilm-resistant (meth-)acrylate-based polymers. These 
predictions are validated successfully by the synthesis of new monomers 
which are polymerized to create coatings found to be resistant to biofilm 
formation by six different bacterial pathogens: Pseudomonas aeruginosa, 
Proteus mirabilis, Enterococcus faecalis, Klebsiella pneumoniae, Escherichia 
coli, and Staphylococcus aureus.
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commercially available alcohols (thousands are readily available) 
to create bespoke monomer building blocks that significantly 
expand the chemical space relative to the commercial (meth)
acrylates used to date. Typical polymer microarray approaches 
use unbiased screening of as wide a range of materials or “chem-
ical space” as possible to maximize the chances of identifying 
hit materials that surpass the performance of existing material 
solutions. To date, this process has been very successful in iden-
tifying a class of monomers that surpass conventional silicone 
catheters for preventing catheter-associated urinary tract infec-
tions, resulting in the granting of a CE mark for a urinary cath-
eter device.[16,19,22] To guide synthesis beyond the commercially 
available compounds computational modeling has been used to 
generate structure–function relationships that can predict the 
biological performance of virtual materials.[23–25] In the case of 
bacterial biofilm formation a simple parameter combining the 
partition coefficient (logP) and the number of rotatable bonds 
for hydrocarbon acrylate pendant groups pointed towards a 
route to a more targeted approach for materials discovery, 
although until now this has not been experimentally validated 
(Figure 1a).[26] Here, we validate a modification of that QSAR by 
extrapolating from the correlation identified between the bac-
terial biofilm formation and a monomer molecular descriptor 
parameter, alpha, to predict novel biofilm resistant monomers 
which were not included in the initial library.
Alpha comprises the log of the calculated partition coef-
ficient (clogP) and the number of rotatable bonds (nRotB), 
alpha = 0.44nRotB−clogP for each monomer previously devel-
oped from a polymer microarray library.[26] Using this as a 
starting point, a polymer of the novel monomer cyclo dodecyl 
methacrylate (CyDMA) was predicted to offer improved 
prevention of biofilm formation by virtue of its low (−5.47) alpha 
value. Here we confirm this prediction both using polymer 
microarray screening experiments and subsequent multigram 
synthesis of both monomer and polymer. The alpha parameter 
was also shown to be valid for a range of other bespoke mate-
rials synthesized with values outside of the previously accessed 
range using commercially available monomers (of −2.81 to 
1.10). Upon scale-up, pCyDMA produced an average 55-fold 
reduction in individual surface coverage for all six bacterial 
pathogens compared with silicone catheters, and 14-fold com-
pared to silver hydrogel coated catheters. pCyDMA coatings on 
average showed a fourfold reduction in biofilm formation for the 
six pathogens compared to a previously identified hit polymer 
coating (poly(ethylene glycol dicyclopentyl ether acrylate-co-
diethyleneglycol methacrylate p(EGDPEA-co-DEGMA)).
The molecular structures of several monomers with low alpha 
parameter values were identified for synthesis, shown in Figure 1b, 
to expand the chemical space in order to identify improved mate-
rials. This also tested the validity of correlation between bacterial 
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Figure 1. a) Process for developing and validating a predictive model at the microscale level including testing on a medical device. Hundreds of 
commercially available materials are assessed for their ability to reduce bacterial biofilm formation via high throughput screening. Processed data 
is used to identify a “hit” material and scaled-up to coat medical devices for confirmatory in vitro studies. Analyzed data together with material 
properties are used to generate models that predict new untested materials which are synthesized and reincorporated into the materials library for 
further screening. This repeated cycle refines the theoretical model and makes it a more powerful predictor of “hit” performance. b) Materials library 
made up of 12 monomers positioned along the alpha value vertical axis. c) Reaction scheme for the transesterification synthesis reaction at 160 °C 
with titanium butoxide (TNBT) catalyst. d,e) ToF SIMS ion images from one replicate area of the microarray corresponding to C2H3O2− (m/z 59.02) (d) 
and C4H9+ (m/z 57.07) (e), both displayed from 0 to 15 normalized counts. f) Graphs of normalized ion intensity (NII) for representative SIMS ions 
for copolymers of tBCHA with CyDMA, The content (%) of each monomer is indicated below graph. The representative ion for tBCHA is C10H17O− 
indicative of tBCHA (R2  = 0.68) and C12H23O− indicative of CyDMA (R2  = 0.97).
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biofilm formation and the alpha parameter beyond the initial 
library limited to commercially available compounds. An alpha 
value of −5.47 was calculated for CyDMA and −3.51 for 5-methyl-
2-(1-methylethyl) cyclohexyl methacrylate (LMMA), which is lower 
than all materials previously tested (alpha = −3 to 1).[26]
Four monomers were successfully synthesized using the one-
step transesterification route (Figure S1a, Supporting Informa-
tion), (CyDMA, trans-3,7-dimethyl-2,6-octadienyl methacrylate 
(GeMA), LMMA, dodecyl methacrylate (DdMA)) outlined in 
Figure 1b, with conversions of 92%, 82%, 69%, and 92%, respec-
tively (see Figures S1–S5 in the Supporting Information for NMR 
spectroscopy studies). In addition to the four synthesized mono-
mers, eight commercially available monomers that had been 
previously tested were also included for comparison. A polymer 
microarray was printed using 11 monomers with an alpha value 
range of −5.47 to 1.1 mixed pairwise with tert-butyl cyclohexyl 
acrylate (tBCHA) to produce unique polymer spots printed 
in triplicate on a single slide after photo polymerization with 
an alpha value range of −5.47 to 1.1 (Figure 1b). Time-of-flight 
secondary ion mass spectrometry (ToF-SIMS) was employed to 
monitor spot printing fidelity and provide surface analysis to 
detect any surface segregation due to demixing of monomers 
(Figure 1d–f).[27] Unique ions were identified for most mono-
mers and used to monitor the relationship between monomer 
feed ratio and the surface composition of the polymer product. 
The ion intensities indicate linear trends for the SIMS ion inten-
sity versus composition when mixing the two monomers, cyclo-
dodecyl methacrylate (CyDMA) and tert-butyl cyclohexyl acrylate 
(tBCHA) (Figure 1f) with correlation coefficients of R2 = 0.97 
and R2 = 0.68 respectively. In both cases the pure monomers 
exhibit slightly higher intensity than predicted by a straight-line 
fit to all the data, suggesting possible matrix effect nonlinearity. 
All the copolymer series were found to approximate to the bulk 
ratios apart from 6-octadienyl methacrylate (GeMA) and ethylene 
glycol phenyl ether acrylate (EGPhEA) where surface segrega-
tion when mixed with tert-butyl cyclohexyl acrylate was inferred 
(Figure S8, Supporting Information). This is likely due to differ-
ences in the miscibility of the monomers causing phase sepa-
ration before polymerization is complete—copolymers which 
exhibited this were not studied further herein.[28]
To determine whether unreacted reagents (monomers and 
their associated alcohols) could inhibit bacterial growth and 
hence reduced bacterial attachment and biofilm formation, 
P. aeruginosa was cultured over 24 h in RPMI media dosed 
with monomers and the associated alcohols at concentrations 
of 0.01%–0.1% (v/v) (Figures S9 and S10, Supporting Informa-
tion). Further bacterial growth studies were conducted on the 
catalysts and the scaled-up monomers for all six pathogens 
(Figures S11 and S12, Supporting Information). No bacterio-
static or bactericidal effects were observed, with the exception 
of LMMA which caused a 50% reduction in growth compared 
with the untreated control. Therefore, materials containing 
LMMA were omitted from the subsequent polymer microarray 
analysis. It is also possible that esterase enzymes produced by 
bacteria could cleave and release pendant alcohol groups that 
contribute to the lack of biofilm formation on resistant mate-
rials. To investigate whether this was a factor, degradation of 
benzyl methacrylate polymer sample was quantified after treat-
ment with fast-acting porcine liver esterase (PLE) over 2 h; no 
degradation was observed for the polymers, in contrast to the 
monomers which were readily cleaved (Figures S13–S16, Sup-
porting Information). It is likely that the increased steric hin-
drance and/or the electronic stability of the ester moiety in 
poly(acrylates) prevented cleavage of the polymer side chains. 
These results suggest that the biofilm inhibition observed on 
all polymers (excepting LMMA) was not influenced by soluble 
compounds released from the materials, but instead by the 
response of the bacterial to the polymer surface.
The human pathogenic bacteria P. aeruginosa, Pr. mirabilis, 
and S. aureus were chosen for initial biofilm formation 
experiments with polymer microarrays, shown in Figure 2, as 
they include both gram-positive (S. aureus) and gram-negative 
(P. aeruginosa, Pr. mirabilis) bacterial species, and are frequently 
associated with healthcare-associated infections including 
catheter-associated urinary tract infections (CAUTI).[29]
A linear correlation (R2 = 0.77) was observed between the bac-
terial load measured as fluorescence intensity of P. aeruginosa  
versus alpha between −3 and 1.1 (Figure 2c).[26] However, 
when materials in the extended range of alpha of −5.47 to 1.1 
were considered, a poorer linear correlation (R2 = 0.61) was 
observed. As alpha decreased, bacterial fluorescence approached 
a lower limit under these microarray assay conditions. An expo-
nential fit better described the relationship between alpha and 
P. aeruginosa attachment for the full polymer library dataset 
(R2 = 0.79) (Figure 2c). While weaker correlation was observed 
for Pr. mirabilis (R2 = 0.52) (Figure 2d), these correlations sug-
gest that both species respond to the physicochemical proper-
ties described by the alpha value (hydrophilicity and molecular 
rigidity). Attachment of S. aureus, a nonmotile gram-positive 
bacterial species, showed no correlation with alpha suggesting 
that other factors are dominant (Figure S17, Supporting Infor-
mation). As the lowest alpha parameter materials were statisti-
cally similar for both bacterial species, the CyDMA homopol-
ymer was taken forward for further investigation as a coating 
on silicone catheter segments in order to carry out initial com-
parison with the biofouling performance of existing devices.
Polymerization of CyDMA was undertaken using thermal 
polymerization to produce a polymer solution with which to dip-
coat silicone catheter segments. For comparison using the same 
scale-up test, a high performing acrylate copolymer material 
previously reported in the literature to prevent bacterial biofilm 
formation, poly(ethylene glycol dicyclopentyl ether acrylate-co-
diethyleneglycol methacrylate p(EGDPEA-co-DEGMA), was 
similarly polymerized and coated onto silicone catheter seg-
ments.[16] An example of a high alpha value polymer, neopentyl 
glycol propoxylate diacrylate (NGPDA) was polymerized using 
the same route and coated onto catheter sections: NGPDA 
has an alpha value of 2.96 compared to CyDMA (α = −5.47). 
Uncoated silicone catheter and silver hydrogel coated catheters 
were commercially sourced and used as comparators that are 
applied in clinical practice. To mimic environmental conditions 
associated with CAUTI, bacteria were cultured in artificial urine 
(AU) with the five different surfaces to quantify both single 
and mixed species bacterial biofilm formation with 6 clinically 
relevant bacterial species: P. aeruginosa, Pr. mirabilis, E. faecalis, 
K. pneumoniae, E. coli, and S. aureus (Figure 3).
On silicone catheter segments a mean bacterial biomass 
(averaging all six strains) of 25 ± 2.9 µm3/µm2 was observed 
Adv. Mater. 2019, 1903513
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compared with the reduced load of 6.4 ± 2.2 µm3/µm2 on a 
commercial silver hydrogel coated catheter (Figure 3a). In 
contrast, the pCyDMA coated catheter segment successfully 
prevented biofilm formation by all six individual bacterial 
species with a mean biomass of only 0.5 ± 0.2 µm3/µm2 as 
shown in Figure 3a,b. The p(EGDPEA-co-DEGMA)[16] coating 
also performed well, with a mean biomass of 1.6 ± 0.4 µm3/µm2, 
although this was surpassed in performance by the pCyDMA 
discovered in this QSAR process. The high alpha value polymer, 
pNGPDA, performance was consistent with the microarray 
relationships identified, with an average biomass of 21.9 ± 
3.4 µm3/µm2, showing an approximate 44-fold greater biomass 
compared with pCyDMA.
Most CAUTI infections are polymicrobial.[30] To test the bio-
film resistance of a dual species biofilm, we used GFP-labeled 
S. aureus SH1000 (green) and mCherry labeled P. aeruginosa 
(red) inoculated onto the catheter segments in a 10:1 ratio. 
Figure 3c–e shows that for silicone, pCyDMA, and p(EGDPEA-
co-DEGMA) after 72 h incubation, the dual species biofilm 
completely covered the silicone surface, whereas very little 
biofilm coverage was observed on p(EGDPEA-co-DEGMA) and 
was almost completely absent on pCyDMA and the quantifica-
tion of this mixed biofilm can be found in Figure S18 in the 
Supporting Information.
In summary, we have used a QSAR model (alpha) to suc-
cessfully predict bacterial biofilm formation on a new polymer 
(pCyDMA) which we synthesized along with others using 
a polymer microarray. Coating of catheter segments with 
pCyDMA reduced biofilm formation by six commonly associ-
ated urinary tract pathogens by 32–300 fold (average 55 fold) 
compared with an uncoated silicone catheter and 9–85 fold 
(average 14 fold) compared with a commercial silver hydrogel 
coated catheter. This polymer coating outperformed our previ-
ously identified best polymer (pEGDPEA) determined by exper-
imental screening using a high throughput discovery approach 
with an average fourfold improvement. Furthermore, pCyDMA 
was also shown to prevent the formation of dual-species 
biofilm in artificial urine, exemplifying the uses of the mate-
rial in a more realistic medical-device-associated infection sce-
nario. This illustrates how validated QSAR models with simple 
physical molecular descriptions can be used to predict novel 
materials that improve on previously established materials 
that have great potential to reduce medical-device-associated 
infections.
Experimental Section
Materials: All materials were used as supplied without further 
purification unless otherwise stated in the preparations detailed below.
Transesterification Experiments: In a typical reaction butyl methacrylate 
(Sigma-Aldrich) (14 g, 98.5 mmol) was introduced into a 50 mL 
vessel along with the required quantity of individual target alcohols 
[cyclododecanol (VWR) (13 g, 70.5 mmol), trans-3,7-dimethyl-
2,6-octadien-1-ol (10.8 g, 70.3 mmol) 5-methyl-2-(1-methylethyl) 
Adv. Mater. 2019, 1903513
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Figure 2. a) Results from polymer microarray biological assay with mCherry tagged P. aeruginosa. Monomer identity is organized into rows and mixing 
ratio columns with tert-Butyl cyclohexyl acrylate (tBCHA). The center square is the fluorescence value for attachment of P. aeruginosa (red indicating 
high bacterial adhesion and white low bacterial adhesion), whilst the narrow columns to the left or right indicate ± 1 sd unit respectively (N = 3). 
b) Results from the same experiment as inset (a) but with dsRed tagged Pr. mirabilis (n = 3). c) Fluorescence intensity measured from P. aeruginosa 
attachment to the polymer microarray. The unfilled/solid black symbols represent materials used to build the alpha model (homopolymers/copolymers 
respectively), the dashed black line is the linear relationship from −3 to 1.1, R2 = 0.75. The red unfilled/solid symbols are materials used to extend alpha 
range (homopolymers/copolymers respectively) and red solid line is exponential relationship with values from −5.47 to 1.1, R2 = 0.79, error bars shown 
are ± 1 sd (n = 3). d) Fluorescence from Pr. mirabilis attachment to the polymer library using the same display conventions as for (c).
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cyclohexanol (11.2 g, 71.6 mmol) or 1-dodecanol (Sigma-Aldrich) (13.1 g, 
70.3 mmol)] to form a 7:5 molar ratio. Then titanium butoxide (Sigma-
Aldrich) catalyst at a concentration of 1% by molar ratio (relative to 
butyl methacrylate) and 1000 ppm of 4-methoxyphenol (Sigma-Aldrich) 
inhibitor were added. The reaction was heated to 160 °C and stirred for 
45 min at which point a nitrogen gas sparge was introduced to increase 
the rate of removal of butanol by-product. Butyl methacrylate has been 
chosen as the methacrylate precursor for these reactions to allow these 
elevated temperatures to drive the reaction kinetics and equilibrium 
toward full completion in a short timescale. The reaction was sampled 
every 15 min and these samples were quenched in a freezer prior to 
NMR analysis.
Bacterial Strains and Growth Conditions: Pr. mirabilis strain Hauser 
1885, P. aeruginosa strain PAO1 (Washington sub-line, Nottingham 
collection), S. aureus SH1000, E. faecalis NCTC12697, K. pneumoniae 
NCIMP10104, and uropathogenic Escherichia coli (UPEC) were routinely 
grown at 37 °C in lysogeny broth (LB) with shaking at 200 rpm or 
on LB agar (2% w/v). Where required, plasmids for constitutively 
expressing fluorescent proteins GFP (pBK-miniTn7-egfp) and mCherry 
(pMMR) were introduced into the relevant host strain by conjugation or 
electroporation.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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Figure 3. a) Surface coverage by single species (E. faecalis, K. pneumoniae, E. coli, Pr. mirabilis, P. aeruginosa, and S. aureus) biofilms quantified after 
72 h incubation on silicone, silver hydrogel, pNGPDA, pCyDMA, and p(EGDPEA-co-DEGMA) (labeled EGDPEA) coated silicone catheter segments 
in AU. Error bars equal ± 1 sd unit, n = 3. b) The corresponding confocal microscopy images for Syto64 stained E. faecalis, K. pneumoniae, E. coli, 
Pr. mirabilis, P. aeruginosa, and S. aureus growing on each polymer surface. Each image is 160 × 160 µm. c) 3D representation and transverse view 
of a dual-species biofilm formed on glass: GFP-tagged S. aureus SH1000 (green) and mCherry labeled P. aeruginosa (red) in a 10:1 ratio. d–e) Three 
dimensional representation and transverse view showing the lack of mature biofilm on pCyDMA and pEGDPEA. Scale bars represent 50 µm.
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